2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
Sydney, Australia
Countries of investment
  • Australia
  • New Zealand
  • United States
  • United Kingdom
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
Industries
  • Space
  • Food
  • Industry
  • Health
  • Sustainability
  • DeepTech
  • Advanced Manufacturing
  • Biotech
  • AI
  • Quantum
About
Main Sequence is a Sydney-based venture capital firm focused on backing deep tech founders addressing humanity's greatest challenges. Their focus spans space, food, industry, health, and sustainability across Australia, New Zealand, United States, and United Kingdom. The firm supports deep tech founders from pre-seed through Series B stages.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

Main Sequence is a pre-seed to Series B stage venture capital firm deploying capital across space, food, industry, health, and sustainability sectors. They invest in deep tech companies solving humanity's biggest challenges, with strong ties to CSIRO (Australia's national science agency) providing access to research and IP. The firm differentiates itself as Australia's national deep tech investor, backed by CSIRO, with $1B+ AUM across three funds and unique access to Australian scientific research infrastructure.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Founded in 2017 as CSIRO's dedicated venture capital fund, led by Bill Bartee (Managing Partner and Co-founder), Mike Zimmerman (Managing Partner and Co-founder, former partner at Blackbird Ventures), Phil Morle (Partner, co-founder of Pollenizer and executive at Amazon Studios), and Martin Duursma (Partner, former Vice President and Chief Scientist at Citrix). Team of 15+ investment professionals operating from Sydney with additional presence across Australia. Manages three funds totaling over $1B AUD in AUM. Backed by CSIRO (Australia's national science agency), Australian Government, and institutional investors. Portfolio of 60+ deep tech companies including Q-CTRL (quantum computing), Vow (cultivated meat), Samsara Eco (plastic recycling), Cortical Labs (biological computing), Advanced Navigation, and Loam Bio. Provides portfolio companies with unique access to CSIRO's research capabilities, IP, and scientific infrastructure.

Main Sequence Ventures Contacts Information

Primary contact

Secondary contact

Team

Bill Bartee - Managing Partner & Co-founder

Mike Zimmerman - Managing Partner & Co-founder

Phil Morle - Partner

Martin Duursma - Partner

Gabrielle Munzer - Partner

Rob Rugman - Partner

Portfolio

Q-CTRL

Vow

Samsara Eco

Cortical Labs

Advanced Navigation

Loam Bio

Baraja

Endua

HB11 Energy

Emesent

MicroTau

Xefco

Nourish Ingredients

PYX Global

Cauldron

EX-Fusion

Nomad Atomics

MicroTau

Cortical Labs

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp